receptors, ampa

Preferred Label : receptors, ampa;

MeSH definition : A class of ionotropic glutamate receptors characterized by their affinity for the agonist AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid).;

MeSH synonym : receptor, ampa; receptor, quisqualate; ampa receptor; ampa receptors; quisqualate receptor; quisqualate receptors; receptors, quisqualate;

Wikipedia link : https://en.wikipedia.org/wiki/Ampa receptor;

Is substance : O;

Détails

Origin ID

D018091;

UMLS CUI

C0072899;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- physiology [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- AMPA glutamate receptor complex [GO term]
Indexing information
- ((6-ethyl-7-nitro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-ylmethyl)methylamino)acetic acid [MeSH Supplementary Concept]
- 1,2-bis-nitrooxy-3-thiocyanatopropane [MeSH Supplementary Concept]
- 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido(3,4-f)quinoxaline-2,3-dione [MeSH Supplementary Concept]
- 1-(4-amino-3-chlorophenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one [MeSH Supplementary Concept]
- 1-(4-aminophenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one [MeSH Supplementary Concept]
- 1-(4-aminophenyl)-7,8-(methylenedioxy)-3,5-dihdro-4H-2,3-benzodiazepin-4-one [MeSH Supplementary Concept]
- 1-(quinoxalin-6-ylcarbonyl)piperidine [MeSH Supplementary Concept]
- 1-hydroxy-7-(1H-imidazol-1-yl)-6-nitro-2,3(1H,4H)-quinoxalinedione [MeSH Supplementary Concept]
- 2,3-dimethyl-6-phenyl-12H-(1,3)dioxolo(4,5-h)imidazo(1,2-c)(2,3)benzodiazepine [MeSH Supplementary Concept]
- 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline [MeSH Supplementary Concept]
- 2-((4-aminophenyl)-(4-methylsemicarbazono)methyl)-4,5-methylenedioxyphenylacetic acid methyl ester [MeSH Supplementary Concept]
- 2-(N-(4-chlorophenyl)-N-methylamino)-4H-pyrido(3,2-e)-1,3-thiazin-4-one [MeSH Supplementary Concept]
- 2-Fu-AMPA [MeSH Supplementary Concept]
- 2-acetyl-1-(4'-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline [MeSH Supplementary Concept]
- 2-amino-3-(2-(2-carboxyethyl)-5-chloro-4-nitrophenyl)propionic acid [MeSH Supplementary Concept]
- 2-amino-3-(3-(2-carboxyethyl)-5-methyl-4-isoxazolyl)propionic acid [MeSH Supplementary Concept]
- 2-amino-3-(3-(carboxymethoxy)-5-tert-butyl-4-isoxazolyl)propionic acid [MeSH Supplementary Concept]
- 2-amino-3-(3-carboxy-5-methyl-4-isoxazolyl)propionic acid [MeSH Supplementary Concept]
- 2-amino-3-(3-hydroxy-5-(2-benzyl-2H-5-tetrazolyl)-4-isoxazolyl)propionic acid [MeSH Supplementary Concept]
- 2-amino-3-(3-hydroxy-5-(2-pyridyl)isoxazol-4-yl)propionic acid [MeSH Supplementary Concept]
- 2-amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic acid [MeSH Supplementary Concept]
- 2-amino-3-(5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl)propionic acid [MeSH Supplementary Concept]
- 3,5-dihydro-5-methyl-7,8-methylenedioxy-4H-2,3-benzodiazepin-4-one [MeSH Supplementary Concept]
- 3a,5,6,6a-tetrahydro-4H-pyrrolo(3,4-d)isoxazole-3,4-dicarboxylic acid [MeSH Supplementary Concept]
- 4,5-Dihydro-7,8-dimethoxy-1-phenyl-3H-2,3-benzodiazepin-4-one [MeSH Supplementary Concept]
- 4,5-dihydro-7-nitro-4-oxo-8-(3-carboxypyrrol-1-yl)-1,2,4-triazolo(1,5-a)quinoxaline-2-carboxylic acid [MeSH Supplementary Concept]
- 4-ethyl-2,3-dihydro-4H-pyrido(3,2-e)-1,2,4-thiadiazine 1,1-dioxide [MeSH Supplementary Concept]
- 5-chlorowillardiine [MeSH Supplementary Concept]
- 6-(4-pyridinyl)-1H-1,2,3-triazolo(4,5-d)pyrimidin-4(5H)-one [MeSH Supplementary Concept]
- 8-methylureido-4,10-dihydro-4-oxo-4H-imidazo(1,2-a)indeno(1,2-e)pyrazin-2-carboxylic acid [MeSH Supplementary Concept]
- Anti-AMPAR antibody [MeSH Supplementary Concept]
- BDP 20 [MeSH Supplementary Concept]
- CP 465,022 [MeSH Supplementary Concept]
- CP 526,427 [MeSH Supplementary Concept]
- CPW 399 [MeSH Supplementary Concept]
- Cacng2 protein, rat [MeSH Supplementary Concept]
- Cacng4 protein, rat [MeSH Supplementary Concept]
- GRIP2 protein, human [MeSH Supplementary Concept]
- GYKI 52466 [MeSH Supplementary Concept]
- GYKI 53655 [MeSH Supplementary Concept]
- GYKI 53784 [MeSH Supplementary Concept]
- Grip2 protein, mouse [MeSH Supplementary Concept]
- Grip2 protein, rat [MeSH Supplementary Concept]
- IEM 1460 [MeSH Supplementary Concept]
- IEM 1913 [MeSH Supplementary Concept]
- IKM 159 [MeSH Supplementary Concept]
- KRP 199 [MeSH Supplementary Concept]
- LU 112313 [MeSH Supplementary Concept]
- LU 115455 [MeSH Supplementary Concept]
- LU 136541 [MeSH Supplementary Concept]
- LU 78919 [MeSH Supplementary Concept]
- LU 97175 [MeSH Supplementary Concept]
- LY 246492 [MeSH Supplementary Concept]
- LY 392098 [MeSH Supplementary Concept]
- LY 404187 [MeSH Supplementary Concept]
- N-(5-(6-fluoro-3-pyridinyl)-2,3-dihydro-1H-inden-2-yl)-2-propanesulfonamide [MeSH Supplementary Concept]
- N-2-(4-(N-benzamido)phenyl)propyl-2-propanesulfonamide [MeSH Supplementary Concept]
- N-2-(4-benzamidophenylpropyl-2-propanesulfonamide) [MeSH Supplementary Concept]
- NS 257 [MeSH Supplementary Concept]
- PD 152247 [MeSH Supplementary Concept]
- SPD 502 [MeSH Supplementary Concept]
- TARP gamma-4 protein, mouse [MeSH Supplementary Concept]
- TARP gamma-7 protein, mouse [MeSH Supplementary Concept]
- YM 872 [MeSH Supplementary Concept]
- cyclothiazide [MeSH Supplementary Concept]
- ethyl 4,5-dihydro-7-nitro-4-oxo-8-(3-carboxypyrrol-1-yl)-1,2,4-triazolo(1,5-a)quinoxaline-2-carboxylate [MeSH Supplementary Concept]
- glr-1 protein, C elegans [MeSH Supplementary Concept]
- milacemide [MeSH Supplementary Concept]
- perampanel [MeSH Supplementary Concept]
- talampanel [MeSH Supplementary Concept]
- tezampanel [MeSH Supplementary Concept]
- tricholomic acid [MeSH Supplementary Concept]
Record concept(s)
- receptors, AMPA [MeSH concept]
Related MeSH Supplementary Concept(s)
- CNIH-1 protein, rat [MeSH Supplementary Concept]
- CNIH2 protein, mouse [MeSH Supplementary Concept]
- CNIH3 protein, human [MeSH Supplementary Concept]
- CNIH3 protein, mouse [MeSH Supplementary Concept]
- Cacng5 protein, rat [MeSH Supplementary Concept]
- Cacng7 protein, rat [MeSH Supplementary Concept]
- Cnih2 protein, rat [MeSH Supplementary Concept]
- Cnih3 protein, rat [MeSH Supplementary Concept]
- Cnih4 protein, rat [MeSH Supplementary Concept]
- GLR-2 protein, C elegans [MeSH Supplementary Concept]
- GLR-5 protein, C elegans [MeSH Supplementary Concept]
- glr-1 protein, C elegans [MeSH Supplementary Concept]
- glutamate receptor ionotropic, AMPA 1 [MeSH Supplementary Concept]
- glutamate receptor ionotropic, AMPA 2 [MeSH Supplementary Concept]
- glutamate receptor ionotropic, AMPA 3 [MeSH Supplementary Concept]
- glutamate receptor ionotropic, AMPA 4 [MeSH Supplementary Concept]
- glutamate receptor type B [MeSH Supplementary Concept]
- pep2-SVKI [MeSH Supplementary Concept]
See also
- alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid [MeSH Descriptor]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Receptor [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients